Nebulized versus subcutaneous morphine for patients with cancer dyspnea: A preliminary study

Journal of Pain and Symptom Management

Volumn 29, Issue 6, 2005, Pages 613-618

  Bruera, Eduardo ^a   Sala, Raul ^b   Spruyt, Odette ^c   Palmer, J Lynn ^a   Zhang, Tao ^a   Willey, Jie ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Hospital Eva Peron   (Argentina)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Dyspnea; Nebulization; Opioids; Subcutaneous Injection

Indexed keywords

MORPHINE; OPIATE;

ADULT; AGED; ARTICLE; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 20444485644     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2004.08.016     Document Type: Short Survey

References (18)

1. E. Bruera, C. Sweeney, and C. Ripamonti Management of dyspnea A. Berger R. Portenoy D. Weissman Principles and practice of palliative care and supportive oncology 2002 Williams & Wilkins Philadelphia 357 371
2. C. Ripamonti, F. Fulfaro, and E. Bruera Dyspnoea in patients with advanced cancer: incidence, causes and treatments Cancer Treat Rev 24 1998 69 80
3. E. Bruera, T. MacEachem, and C. Ripamonti Subcutaneous morphine for dyspnea in cancer patients Ann Intern Med 119 1993 906 907
4. C. Mazzocato, T. Buclin, and C. Rapin The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double blind controlled trial Ann Oncol 10 1999 1511 1514
5. E. Bruera, K. Macmillan, and J. Pither Effects of morphine on the dyspnea of terminal cancer patients J Pain Symptom Manage 5 1990 341 344
6. A. Abernathy, D. Currow, and P. Frith Randomized, double-blind, placebo-controlled crossover trial of sustained release morphine for the management of refractory dyspnea Br Med J 327 7414 2003 523 528
7. S. Chandler Nebulized opioids to treat dyspnea Am J Hospice Palliat Care 16 1999 418 422
8. A. Masood, K. Macmillan, and J. Pither Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects Br J Clin Pharmacol 41 1996 250 252
9. P. Quelch, D. Faulkner, and J. Yun Nebulized opioids in the treatment of dyspnea J Palliat Care 13 1997 48 52
10. C. Davis, W. Lam, and M. Butcher Low systemic bioavailability of nebulized morphine: Potential therapeutic role for the relief of dyspnea Proc Ann Meeting Am Soc Clin Oncol 11 1992 A359
11. W. Stein, and Y. Min Nebulized morphine for paroxysmal cough and dyspnea in a nursing home resident with metastatic cancer Am J Hospice Palliat Care 14 1997 52 56
12. C. Davis, K. Penn, and R. A'Hern Single-dose randomized controlled trial of nebulized morphine in patients with cancer related breathlessness Palliat Med 10 1996 64 65
13. A. Masood, J. Reed, and S. Thomas Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease Thorax 50 1995 629 634
14. C. Davis, C. Hodder, and S. Love Effect of nebulized morphine and morphine 6-glucuronide on exercise endurance in patients with chronic obstructive airway disease Thorax 49 1994 393
15. A.L. Jennings, A.N. Davies, and J.P. Higgins A systematic review of the use of opioids in the management of dyspnea Thorax 57 2002 939 944
16. R. Polosa, A. Simidchiev, and E.H. Walters Nebulised morphine for severe interstitial lung disease Cochrane Database Syst Rev 3 2002 CD002872
17. E. Bruera, N. de Stoutz, and A. Velasco-Leiva Effects of oxygen on dyspnea in hypoxaemic terminal-cancer patients Lancet 342 1993 13 14
18. S.E. Zebraski, S.M. Kochenash, and R.B. Raffa Lung opioid receptors: Pharmacology and possible target for nebulized morphine in dyspnea Life Sci 66 2000 2221 2231